glp 1 agonist drug names America's Poison Centers GLP-1 Drug Comparison in Diabetes
Description
Rev Endocrine Metab Disord (2022) 23(3):52139

To view or add a comment, sign in 1,606 followers
This review delves into the pathogenesis of diabetes mellitus and CKD, highlighting the unique challenges these complications present in liver transplant recipients

Avoiding high-fat foods is particularly important, as dietary fat further delays gastric emptying beyond the medication's effect
While side effects like nausea are common, theyre usually mild and temporary

Tirzepatide, a dual agonist of GIP and GLP-1 receptors, was approved for T2DM in 2022 and obesity/overweight in 2023 [33]
